Pharvaris N.V. (PHVS) Institutional Ownership

Ownership Summary

A total of 82 institutions have reported a stake in Pharvaris N.V. (NASDAQ:PHVS) as of September 2025, according to recent 13F filings with the SEC.

• The percentage of Pharvaris N.V owned by institutions changed from 82.3% in June 2025 to 105.7% in September 2025, marking a slight up trend.
• Institutional share ownership changed by 28.45% QoQ, while the number of institutional owners saw an increase of 60.78% YoY.
• A review of institutional activity for Pharvaris N.V shows 62 of 82 filers increasing their positions, while 13 reduced their stake, and 7 remained unchanged.
• This class of investors increased its holdings in Pharvaris N.V to 57.84Mn shares for the 13F-cycle ending September 2025, up by 12.81Mn shares quarter on quarter, and up 12.79Mn shares year over year.
• As of September 30, 2025, GENERAL ATLANTIC, L.P. held Pharvaris N.V's largest shareholding position with over 8.03Mn shares, representing 14.67% of total outstanding shares.
• Among the most significant buyers of Pharvaris N.V during September 2025 were EQT Fund Management S.a r.l. (3.42Mn), WELLINGTON MANAGEMENT GROUP LLP (1.73Mn), FMR LLC (976.76K), Saturn V Capital Management LP (886.33K), Paradigm Biocapital Advisors LP (772.58K).
• Leading sellers of Pharvaris N.V stock in September 2025 included VR Adviser, LLC (1.37Mn), SPHERA FUNDS MANAGEMENT LTD. (190.53K), Bain Capital Life Sciences Investors, LLC (122.11K), Cormorant Asset Management, LP (91.46K), Soleus Capital Management, L.P. (85.92K).
• The top 10 institutional holders of Pharvaris N.V for the quarter ending September 2025 included GENERAL ATLANTIC, L.P. (8.03Mn), FMR LLC (6.40Mn), Foresite Capital Management IV, LLC (4.78Mn), venBio Partners LLC (4.64Mn), VIKING GLOBAL INVESTORS LP (3.65Mn), EQT Fund Management S.a r.l. (3.42Mn), Bain Capital Life Sciences Investors, LLC (3.18Mn), DEERFIELD MANAGEMENT COMPANY, L.P. (2.44Mn), Commodore Capital LP (2.42Mn), Paradigm Biocapital Advisors LP (1.84Mn).